Trial Profile
Dose-Ranging Study in Patients With COPD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Therapeutic Use
- 01 Jul 2008 Primary endpoint 'Pulmonary function' has been met.
- 24 Feb 2006 New trial record.